Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis
- 10 December 2008
- journal article
- clinical trial
- Published by Wiley in Liver International
- Vol. 11 (1), 30-38
- https://doi.org/10.1111/j.1600-0676.1991.tb00487.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non‐A, non‐B hepatitis with or without antibodies to hepatitis CLiver International, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus AntibodiesScandinavian Journal of Infectious Diseases, 1989
- Long‐term follow‐up of chronic post‐transfusion non‐A, non‐B hepatitis: clinical and histological outcomeLiver International, 1988
- The application of a numerical scoring system for evaluating the histological outcome in patients with chronic hepatitis B followed in long termHepatology, 1988
- Liver Investigation in 149 Asymptomatic Patients with Moderately Elevated Activities of Serum: AminotransferasesScandinavian Journal of Gastroenterology, 1986
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981